Become our partner
We believe in the power of collaboration to accelerate the discovery and delivery of life-changing cancer treatments. By joining forces with Australis, you can make a profound impact on global health and provide hope to patients in need.
Why partner with us
Innovative cancer treatment
AUS_001 shows pre-clinical efficacy across 24 cancer types, including hard-to-treat cancers such as pancreatic and brain.
Untapped natural compounds
Australis is unlocking the vast potential of natural plant molecules. Through honeybee intelligence, we have discovered 19 novel compounds, and secured IP protection for these natural compounds and a chemical derivative library covering thousands of molecular structures. These are accelerating the development of new treatments from an underexplored area.
Expert leadership and collaboration
With a world-class team and leading scientific partners, Australis is positioned to revolutionize cancer treatment across multiple therapeutic areas.
Ongoing studies
The following includes ongoing and planned in vivo efficacy studies for AUS_001.
Pancreatic cancer.
Breast cancer.
Melanoma.
Glioblastoma.
Diffuse intrinsic pontine glioma (DIPG).
Interested in partnering?
Based on the encouraging in vitro and in vivo data for AUS_001, Australis is preparing the final studies required to be clinic-ready. This is your chance to join us.